Literature DB >> 10811997

Expression of MTA1, a metastasis-associated gene with histone deacetylase activity in pancreatic cancer.

H Iguchi1, G Imura, Y Toh, Y Ogata.   

Abstract

MTA1 has been identified as a metastasis-promoting gene, and its gene expression is correlated with serosal invasion and lymph node metastasis in the gastrointestinal and esophageal cancers. We examined MTA1 mRNA expression levels in 13 cell lines and 23 tumor tissues of pancreatic cancer by quantitative reverse transcription polymerase chain reaction. MTA1 mRNA expression was found in all the cell lines, however its levels were not correlated with the metastatic pontential of each cell line representing hematogenous distant metastasis. In the pancreatic cancer tissues, the overexpression of MTA1 mRNA (tumor/normal ratio >/=1) was observed in 12 out of 23. Pancreatic cancer tissues overexpressing MTA1 mRNA (T/N ratio >/=1) tended to have higher incidence of lymph node metastasis. These results together with previous findings in the gastrointestinal and esophageal cancers suggest that MTA1 might be involved in the progression, particularly in lymph node metastasis of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811997     DOI: 10.3892/ijo.16.6.1211

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  18 in total

Review 1.  [Tissue microarrays. High-throughput procedures to verify potential biomarkers].

Authors:  R Kuefer; M D Hofer; J E Gschwend; M A Rubin
Journal:  Urologe A       Date:  2004-06       Impact factor: 0.639

2.  Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors.

Authors:  Cinzia Azzoni; Lorena Bottarelli; Stefano Cecchini; Costanza Lagrasta; Silvia Pizzi; Tiziana D'Adda; Elisa Tamburini; Guido Rindi; Cesare Bordi
Journal:  Virchows Arch       Date:  2011-03-29       Impact factor: 4.064

3.  Relationship between the expression of MTA-1 gene and the metastasis and invasion in human osteosarcoma.

Authors:  Chengla Yi; Xinzhi Li; Weiguo Xu; Anmin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

4.  Overexpression of metastatic tumor antigen in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.

Authors:  Hye-Rim Park; Woon Won Jung; Hyun Sook Kim; Patrizia Bacchini; Franco Bertoni; Yong-Koo Park
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

5.  MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3.

Authors:  Heying Chu; Xudong Chen; Huaqi Wang; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Ping Li; Juan Li; Jingxia Chang; Guoqiang Zhao; Guojun Zhang
Journal:  Tumour Biol       Date:  2013-11-29

Review 6.  Epigenomic regulation of oncogenesis by chromatin remodeling.

Authors:  R Kumar; D-Q Li; S Müller; S Knapp
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

7.  MTA1 expression is linked to ovarian cancer.

Authors:  Masanao Murakami; Rajeev Kaul; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2008-09-30       Impact factor: 4.742

Review 8.  Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.

Authors:  Song He; Dechun Zhang; Fang Cheng; Fanghong Gong; Yanan Guo
Journal:  Mol Biol Rep       Date:  2009-01-01       Impact factor: 2.316

Review 9.  The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.

Authors:  Yasushi Toh; Garth L Nicolson
Journal:  Clin Exp Metastasis       Date:  2008-12-31       Impact factor: 5.150

10.  Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer.

Authors:  Shu-Li Liu; Yang Han; Yong Zhang; Cheng-Yao Xie; En-Hua Wang; Yuan Miao; Hai-Ying Li; Hong-Tao Xu; Shun-Dong Dai
Journal:  Target Oncol       Date:  2012-05-15       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.